ARCHIVES

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

Congressional Committees Add Provisions To Cancer Act Renewal Bills To Strengthen NCI’s Independence, Prevent Fund Withholding

March 8, 1974

Johnson, Katterhagen Applaud CCOP RFA But With It Had Money For More Cancer Control

July 30, 1982

In Brief: Rosenberg, Taniguchi To Share Hammer 1985 Prize; Dennis Cain Moves To DCT From DEA Grants Review

December 6, 1985

Talbot, Schein Ask Weickar for 41.3 Billion for NCI

May 6, 1983

DCPC Concepts Approved For Tw Grants Support Contract

January 31, 1986